Three-Dimensional Echo Decorrelation Imaging for Thermal Ablation of Liver Cancer

  • Increases Procedure Precision
  • Avoids RFA/MWA Overtreatment
  • Allows for Real-Time Monitoring and Control


Liver cancer is common in the United States, with over 36,000 Americans receiving a diagnosis of liver cancer each year. Thermal ablation, including radiofrequency and microwave ablation (RFA and MWA) is a useful treatment for liver cancer, but patient outcomes are inferior to that of surgery. Monitoring and controlling thermal ablation would overcome this limitation and potentially allow for complete treatment without surgery.

Previously, two-dimensional echo decorrelation imaging has been proven to accurately predict local thermal ablation and successfully control RFA, overcoming previous limitations to the success and accuracy of thermal ablation treatments for liver cancer. However, 2D imaging is not sufficient for real-time monitoring of RFA and MWA. 3D echo decorrelation imaging is needed for real-time monitoring and control of thermal ablation. This can help avoid over treatment and further increase procedure precision, leading to improved patient outcomes.

Dr. Mast and his team have developed a method of implementing three-dimensional echo decorrelation imaging for monitoring of thermal ablation. This method has promising applications for cancer treatment, as the results indicate that 3D echo decorrelation imaging is an accurate method of monitoring and controlling clinical thermal ablation for the treatment of liver tumors.

For discussions around learning more or licensing this technology,please contact Madison Bourbon today.

Contact Information

Name: Madison Bourbon


Phone: 513-558-4237